Your browser doesn't support javascript.
In Silico Analysis of Bioactive Compounds from Sea Urchin (Echinometra mathaei) against SARS-COV-2
Biomedical and Pharmacology Journal ; 16(1):329-337, 2023.
Article in English | EMBASE | ID: covidwho-2298195
ABSTRACT
SARS-CoV-2 is a kind of coronavirus that produces Covid-19 illness, which is still a public health concern in Indonesia. Meanwhile, an effective drug has not yet been found and although vaccination has been carried out, in several regions and neighboring countries there is still an increase in Covid-19 cases. This study aimed to obtain bioactive compounds from sea urchins (Echinometra mathaei) that have greater antiviral potential and lower toxicity than remdesivir. This research was started by predicting druglikeness with SwissADME, followed ADMET predicition with pkCSM online, and docking of molecule using the Molegro Virtual Docker (MVD) 5.5 software against the main protease (Mpro) target (PDB ID 6W63). The results showed that six compounds from sea urchins (Echinometra mathaei) had antiviral activity, where the bioactive compound from sea urchins (Echinometra mathaei) with the highest affinity was shown by Spinochrome C a smaller rerank score compared with Remdesivir and native ligand (X77). So that Spinochrome C compounds are candidates as SARS-CoV-2 inhibitors potential developed drug.Copyright Published by Oriental Scientific Publishing Company © 2023.
Keywords
admet; Druglikeness; molecular docking; sars-cov-2; Sea urchin; antiviral activity; article; binding affinity; computer model; controlled study; detoxification; drug metabolism; hydrogen bond; ld50; liver toxicity; nonhuman; particle size; pharmacokinetic parameters; Severe acute respiratory syndrome coronavirus 2; skin permeability; toxicity testing; volume of distribution; animal extract/an [Drug Analysis]; animal extract/dv [Drug Development]; animal extract/pk [Pharmacokinetics]; antivirus agent; cytochrome P450/ec [Endogenous Compound]; cytochrome P450 2D6/ec [Endogenous Compound]; remdesivir; unclassified drug; echinometra mathaei; echinamine 253/an [Drug Analysis]; echinamine 253/dv [Drug Development]; echinamine 253/pk [Pharmacokinetics]; echinamine B/an [Drug Analysis]; echinamine B/dv [Drug Development]; echinamine B/pk [Pharmacokinetics]; echinamine e/an [Drug Analysis]; echinamine e/dv [Drug Development]; echinamine e/pk [Pharmacokinetics]; echinochrome A/an [Drug Analysis]; echinochrome A/dv [Drug Development]; echinochrome A/pk [Pharmacokinetics]; echinometra mathaei extract/an [Drug Analysis]; echinometra mathaei extract/dv [Drug Development]; echinometra mathaei extract/pk [Pharmacokinetics]; n nitrosurea; spinochrome 252/an [Drug Analysis]; spinochrome 252/dv [Drug Development]; spinochrome 252/pk [Pharmacokinetics]; spinochrome 282/an [Drug Analysis]; spinochrome 282/dv [Drug Development]; spinochrome 282/pk [Pharmacokinetics]; spinochrome B; spinochrome C/an [Drug Analysis]; spinochrome C/dv [Drug Development]; spinochrome C/pk [Pharmacokinetics]; spinochrome D/an [Drug Analysis]; spinochrome D/dv [Drug Development]; spinochrome D/pk [Pharmacokinetics]; spinochrome E

Full text: Available Collection: Databases of international organizations Database: EMBASE Language: English Journal: Biomedical and Pharmacology Journal Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: EMBASE Language: English Journal: Biomedical and Pharmacology Journal Year: 2023 Document Type: Article